This paid-for advertorial by Twist Biopharma appeared in DDW Volume 22, Issue 3 – Summer 2021 By Dr Aaron Sato, Chief Scientific Officer, Twist Bioscience The efficiency of candidate antibody discovery pipelines is directly connected to the quality of the DNA library being screened. To reduce discovery timelines, researchers need access to tools allowing them […]
To read this content in full, you need to login.
Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!
